Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Specimen Handling 65Magnetic Resonance Spectroscopy 44Cyclophosphamide 32Carboplatin 31Gemcitabine 30Biopsy 28Cisplatin 25Bevacizumab 25Radiotherapy 24pembrolizumab 23Paclitaxel 23Standard of Care 22Oxaliplatin 22fludarabine 21Nivolumab 21Drug Therapy 21Capecitabine 21venetoclax 20Interviews as Topic 18Injections 17Radiosurgery 16Blood Specimen Collection 16toripalimab 15cemiplimab 15Dexamethasone 15Azacitidine 15tislelizumab 14Irinotecan 14Docetaxel 14anlotinib 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × pirarubicin × 90 days × Clear all
NCT07424287 2026-06-02

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 3 Not yet recruiting
236 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡